Epiodyne

Epiodyne was founded to develop breakthrough small molecule medicines based upon novel insights into GPCR receptor pharmacology that were uncovered by leading researchers at UCSF, Stanford and Duke. Together with our founders and with the highly experienced medicinal chemistry team at R2M Pharma (https://www.linkedin.com/company/r2m-pharma/), we are using quantitative pharmacological and behavioral techniques to translate our insights into novel medicines for patients with opioid use disorder (OUD). We are backed by a syndicate of experienced biotech VCs and located in the Bay Area.

Executive Mindshare

Executive Mindshare is a Social Media Network for industry verticals. Executive Mindshare is designed for a global audience of senior business professionals, policy makers, thought leaders and financial decision-makers in specific vertical business industries. Developed to build the industry influence of business executives, Executive Mindshare delivers relevant and targeted news content, user content and access to a vibrant social network of industry leaders and opinion leaders.

ALCEDIAG

Biomarker-based diagnostics for Mental Health ALCEDIAG is a personalized medicine company specializing in the development of biological signatures aimed to serve as the basis of diagnostics tools, with a primary focus on mental health. These biomarkers are based on the analysis of RNA editing, an epigenetic mechanism altering the nature and conformation of RNA. RNA editing may lead to the production of altered forms of proteins or modify gene expression regulation. RNA editing can be modified in the case of certain diseases, or as a consequence of a medical treatment. ALCEDIAG blood biomarkers already have been proven to be related to mental health conditions such as depression and suicidal tendencies. ALCEDIAG develops EDITDIAG, a blood test to diagnose mental disorders. EDITDIAG has already been clinically tested, showing outstanding sensitivity and specificity, on hundreds of patients and for several pathologies including depression, suicidal tendencies and bipolar disorders. Based on its expertise and experience, ALCEDIAG also developed a platform to discover new biomarkers based on RNA editing. The company exploits this platform for the needs of its own tests and research and collaborates with other entities to discover biomarkers for other pathologies. ALCEDIAG commercializes EDITOX, a predictive test to assess neuropsychiatric adverse effects. EDITOX assesses the risk for drugs to induce severe psychiatric side effects, with a first focus on depression and suicide and then on epilepsy. ALCEDIAG is a subsidiary of Alcen, an industrial group active in the domains of medical & healthcare, defense & security, aeronautics & space, energy and large scientific instruments. ALCEDIAG is currently looking for partners to develop companion diagnostic tests for mental health. Headquarters: Route des Michels CD 56, 13270 Peynier - France R&D: Parc Euromedecine, Cap Delta, 1682 rue de la Valsière, 34184 Montpellier – France

Eurobio-Ingen

Eurobio développe, produit et commercialise des réactifs destinés à la Recherche et au Diagnostic biomédical. Depuis plus de 50 ans, Eurobio accompagne l’évolution de la science et des technologies en fournissant des produits adaptés aux laboratoires de recherche et de diagnostic.

1928 Diagnostics

1928 Diagnostics offer easy-to-use bioinformatic analysis Software-as-a-Service of whole genome sequencing data for infection diagnostics and surveillance. 1928 Diagnostics combines cloud computing and automated bioinformatics into a cloud-based software, capable of handling the large datasets generated from whole genome sequencing machines. The raw data file is simply uploaded, directly from the sequencing machine, to our Software-as-a-Service platform, 1928D. In the platform the data is processed, searching for resistance genes and mutations, as well as typing analysis. The generated resistance and virulence profiles and typing pattern is used by the clinician as a decision support in choosing the right antibiotic treatment and for outbreak control and surveillance.